Prescribing Speed vs. Safety: Which Providers Are Actually Making the Tradeoff

"Get prescribed in minutes" is a common marketing hook — and speed itself isn't the problem. The question is whether that speed comes from genuine efficiency or from skipping the clinical review that's supposed to happen. Here's how providers are actually making that tradeoff.

Where speed comes from legitimately

A well-designed intake process, efficient clinician workflows, and pharmacy partnerships with fast fulfillment can all genuinely speed up the process without cutting corners on the actual evaluation — this is legitimate operational efficiency.

Where speed comes from cutting corners

The Yale secret shopper study found that roughly two-thirds of platforms studied involved zero direct interaction with a prescribing clinician before approval — approval that fast generally means the questionnaire is doing the work a clinician's judgment is supposed to do.

How to actually tell the difference

• Does the platform describe what the clinical review process actually involves, or just promise speed?
• Is there any indication a clinician might follow up with questions based on your specific answers, or is approval unconditional once you submit?
• Does the marketing emphasize speed alone, or speed alongside described clinical rigor?

The honest framework

Fast isn't automatically bad, and slow isn't automatically thorough — but "instant approval with zero clinician interaction," specifically, is the pattern the secret shopper study flagged as concerning. That's the specific thing worth screening for, not speed in general.